Nanoparticle albumin-bound paclitaxel – first step of nanotechnology into clinical practice
Paclitaxel is an effective antitumor agent used for treatment of breast cancer, lung, stomach and pancreas. However, its own adverse effects and the use of toxic Cremophor EL as the solvent limit the application range of this drug. Associated with the albumin-bound nanoparticle paclitaxel (paclitaxe...
Saved in:
Main Authors: | R. N. Alyautdin, B. K. Romanov, В. К. Лепахин, N. D. Bunyatyan, V. A. Merkulov, A. N. Mironov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2022-06-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/300 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of liposome binding antisense oligonucleotide BP1003 on albumin-bound paclitaxel sensitivity in pancreatic cancer cells by inhibiting STAT3
by: FU Hua, ZHOU Guochao, CAI Rongmin, SONG Xin, YANG Dinghua
Published: (2025-05-01) -
Efficacy and safety of nanoparticle albumin-bound paclitaxel in non-small cell lung cancer: a systematic review and meta-analysis
by: Hong Tan, et al.
Published: (2019-12-01) -
Micellar paclitaxel in the treatment of patients with tumors of the female reproductive system
by: A. G. Kedrova, et al.
Published: (2019-11-01) -
PENURUNAN NILAI HANTARAN TULANG PADA PENDERITA KARSINOMA NASOFARING DENGAN KEMOTERAPI BERBASIS PLATINUM: KOMBINASI NEOADJUVANT PACLITAXEL-CISPLATIN DAN PACLITAXEL-CARBOPLATIN
by: Cika Apriliana, et al.
Published: (2019-02-01) -
Comparative acute toxicity of intravenous paclitaxel and sirolimus in rats
by: Jing Xie, et al.
Published: (2025-01-01)